🌐 Entity
Weight loss
Reduction of the total body mass
📊 Rating
2 news mentions · 👍 0 likes · 👎 0 dislikes
📌 Topics
- Regulatory Crackdown (1)
- Pharmaceutical Compliance (1)
- Weight-Loss Drugs (1)
- Direct-to-Consumer Healthcare (1)
- Pharmaceutical innovation (1)
- Combination therapy (1)
- Chronic disease treatment (1)
🏷️ Keywords
Hims & Hers (1) · GLP-1 (1) · FDA (1) · Semaglutide (1) · Compounding Pharmacies (1) · Weight Loss (1) · Telehealth (1) · Regulatory Crackdown (1) · Eli Lilly (1) · Zepbound (1) · Taltz (1) · Psoriasis (1) · Weight loss (1) · Clinical study (1) · Combination therapy (1) · Pharmaceutical innovation (1)
📖 Key Information
In medicine, health, or physical fitness, weight loss is a reduction of the total body mass, by a mean loss of fluid, body fat (adipose tissue), or lean mass (namely bone mineral deposits, muscle, tendon, and other connective tissue). Weight loss can either occur unintentionally because of malnourishment or an underlying disease, or from a conscious effort to improve an actual or perceived overweight or obese state. "Unexplained" weight loss that is not caused by reduction in calorific intake or increase in exercise is called cachexia and may be a symptom of a serious medical condition.
📰 Related News (2)
-
-
🇺🇸 Lilly's Zepbound and Taltz improve psoriasis symptoms, drive weight loss in study
Eli Lilly said on Wednesday the combined use of its weight-loss drug Zepbound with psoriasis treatment Taltz showed better results in a late-stage st...
🔗 Entity Intersection Graph
People and organizations frequently mentioned alongside Weight loss:
-
Telehealth · 1 shared articles -
Semaglutide · 1 shared articles -
Food and Drug Administration · 1 shared articles -
Psoriasis · 1 shared articles -
Eli Lilly · 1 shared articles -
🌐
Ixekizumab · 1 shared articles
-
Tirzepatide · 1 shared articles